| Terminated | A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pa Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | 2023-03-28 |
| Completed | A Study of Multiple-ascending Doses of IW-3300 in Healthy Subjects Healthy Volunteers | Phase 1 | 2022-05-17 |
| Completed | A Study of Single Ascending Doses of IW-3300 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2022-01-18 |
| Completed | A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome Irritable Bowel Syndrome With Diarrhea (IBS-D) | Phase 2 | 2019-05-01 |
| Completed | Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburid Healthy Volunteers | Phase 1 | 2019-03-11 |
| Completed | Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Prot Gastroesophageal Reflux Disease (GERD) | Phase 3 | 2018-09-06 |
| Completed | A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Irritable Bowel Syndrome Characterized by Constipation | Phase 3 | 2018-06-20 |
| Terminated | A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Pr Gastroesophageal Reflux Disease (GERD) | Phase 3 | 2018-06-20 |
| Terminated | A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairmen Gout, Chronic Kidney Disease (CKD) | Phase 4 | 2017-07-19 |
| Terminated | A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Con Irritable Bowel Syndrome Characterized by Constipation | Phase 4 | 2016-12-21 |
| Completed | A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD) Gastroesophageal Reflux Disease | Phase 2 | 2016-03-01 |
| Completed | Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Irritable Bowel Syndrome With Constipation | Phase 2 | 2015-10-22 |
| Completed | Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) Diabetic Gastroparesis | Phase 2 | 2014-10-01 |
| Completed | Trial of Linaclotide in Patients With Chronic Idiopathic Constipation Chronic Idiopathic Constipation | Phase 3 | 2014-10-01 |
| Completed | Ph2a Study to Evaluate IW-3718 in Patients With Gastroesophageal Reflux Not Completely Responsive to Proton Pu Gastroesophageal Reflux | Phase 2 | 2014-02-01 |
| Terminated | Phase 2a Study of IW-9179 to Treat Functional Dyspepsia Dyspepsia, Functional Gastrointestinal Disorders | Phase 2 | 2012-10-01 |
| Completed | Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar Extraction Healthy | Phase 2 | 2010-06-01 |
| Completed | Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) Irritable Bowel Syndrome With Constipation | Phase 3 | 2009-07-01 |
| Completed | An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Irritable Bowel Syndrome With Constipation, Chronic Constipation | Phase 3 | 2008-09-01 |
| Completed | Trial of Linaclotide in Patients With Chronic Constipation Chronic Constipation | Phase 3 | 2008-08-01 |
| Completed | Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irrit Irritable Bowel Syndrome With Constipation | Phase 2 | 2007-04-01 |
| Completed | Study of Oral MD-0727 Administered to Patients With Primary Hypercholesterolemia Hypercholesterolemia | Phase 2 | 2006-11-01 |
| Completed | Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipati Chronic Constipation | Phase 2 | 2006-11-01 |
| Completed | Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipatio Constipation | Phase 2 | 2006-03-01 |
| Completed | Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS Irritable Bowel Syndrome | Phase 2 | 2006-01-01 |